# Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors

> **NCT00944372** · PHASE4 · TERMINATED · sponsor: **Mallinckrodt** · enrollment: 150 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** Indium In-111 pentetreotide

## Key facts

- **NCT ID:** NCT00944372
- **Lead sponsor:** Mallinckrodt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-07
- **Primary completion:** 2005-08
- **Final completion:** 2005-08
- **Target enrollment:** 150 (ACTUAL)
- **Why stopped:** Enrollment was difficult
- **Last updated:** 2016-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00944372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00944372, "Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00944372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*